Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q2 2024 (June 30)18holders +1
3new positions
2sold out
1famous investor
$0.37avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, up 1 from Q1 2024. 3 opened new positions and 2 sold out. The largest holders were Sabby Management, LLC ($497K), UBS Group AG ($53K) and Gagnon Securities LLC ($43K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468202
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $58K |
| Exits | 2 | $270 |
All 13F filers, Q1 2024 → Q2 2024: 286,769 shares bought and 992,365 shares sold, net −705,596 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Sabby Management, LLC | 7.40% | Reduce -42.2% | 1,341,189 | $497K |
| UBS Group AG | 0.00% | Add +181.4% | 142,385 | $53K |
| Gagnon Securities LLC | 0.01% | Reduce -2.0% | 116,020 | $43K |
| Citadel Advisors | 0.00% | New | 108,570 | $40K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +27.5% | 99,877 | $37K |
| Jane Street Group, LLC | 0.00% | New | 47,141 | $17K |
| Virtu Financial LLC | 0.00% | Add +75.3% | 37,114 | $14K |
| Rhumbline Advisers | 0.00% | Reduce -37.3% | 18,927 | $7K |
| Mgo One Seven LLC | 0.00% | No change | 15,750 | $6K |
| Two Sigma Securities, LLC | 0.00% | Add +12.8% | 13,028 | $5K |
| Group One Trading LLC | 0.00% | No change | 615 | $228 |
| Morgan Stanley | 0.00% | Reduce -30.2% | 360 | $134 |
| Bank of America Corp. | 0.00% | Reduce -27.5% | 132 | $49 |
| Flputnam Investment Management Co. | 0.00% | New | 93 | $34 |
| Wells Fargo & Company | 0.00% | No change | 23 | $9 |
| JPMorgan Chase & Co. | 0.00% | No change | 11 | $4 |
| IFP Advisors, Inc | 0.00% | No change | 7 | $3 |
| Royal Bank of Canada | 0.00% | Add +124.3% | 424 | $0 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.